FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Quality Management Pilot for Finished Drugs

Federal Register notice: FDA announces its Quality Management Maturity for Finished Dosage Forms Pilot Program for domestic drug product manufacturers...

Medical Devices

CDRH Posts Videos of Device User Fee Accomplishments

CDRH posts a series of videos highlighting the progress the Center has made to date with implementing the current medical device user fee program.

Federal Register

New eCTD Module Use Requirement

FDA is announcing a requirement for electronic submissions to be submitted using a new Electronic Common Technical Document Module beginning 3/1/2022.

Human Drugs

CDER Starting 2 Quality Management System Pilots

CDER announces two quality management system pilot projects to help inform an agency rating system.

Federal Register

Guide on Nitinol Device Non-Clinical Assessments

Federal Register notice: FDA makes available a final guidance entitled Technical Considerations for Non-Clinical Assessment of Medical Devices contain...

Federal Register

Guide on Device Biocompatibility Info in Submissions

Federal Register notice: FDA makes available a draft guidance entitled Select Updates for Biocompatibility of Certain Devices in Contact with Intact S...

Medical Devices

Many AI/ML Framework Comments Lack Evidence: Study

University of Oxford researchers find that many comments on an FDA framework for modifying artificial intelligence and machine learning-based software...

Human Drugs

See-Mode Tech AI Cleared for Vascular Scans

FDA clears a See-Mode Technologies 510(k) for its Augmented Vascular Analysis, a medical artificial intelligence software for automated analysis and r...

Biologics

AstraZeneca Vaccine Safety Info Slow Coming to FDA: Report

An anonymous source tells CNN that AstraZeneca took several weeks to deliver data to FDA on the Covid vaccine trial participant illness that led to a ...

Human Drugs

FDA Hides Product Names in Serious CAERS Reports: Survey

Consumer Reports says FDA has been inappropriately redacting product names from some dietary supplement adverse event reports covering hospitalization...